Veeva Systems Inc (V2EE34) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Veeva Systems Inc BRL 45.76, price BRL 49.00, upside -6.6%, quality 70 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range R$25.14 – R$61.59 · fair‑value band R$29.74 – R$59.50 · the R$49.00 price screens above the R$45.76 fair value. Dashed = 300-day average. As of Oct 3, 2026.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Show more
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Stock analysis
Veeva Systems Inc (V2EE34) currently trades at R$49.00, while our model-based Fair Value estimate is R$45.76, so the stock looks roughly fairly valued today (gap 7.1%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of R$27.69 per share, and 0 of the 24 models we run sit above the R$49.00 price.
Bear case: the Asset-Based group reads lowest at R$5.17, and 24 of the 24 models stay below the price. Evidence for this calculation is high.
Scenario range: R$29.74 (bear) to R$59.50 (bull), the price of R$49.00 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Veeva Systems Inc reported revenue of $3.2B in FY2026 versus $1.9B in FY2022, a compound +14.6%/yr. Reported net income was $909M in FY2026, compounding +20.8%/yr from FY2022.
Key figures
Market cap R$161B (≈ $30.8B) · P/E ratio 50.5 · P/S ratio 14.4 · EPS (TTM) R$0.9700 · Net margin 28.4% · Return on equity 13.9% · Return on assets (EBIT) 9.9% · Operating margin 30.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 10% below its 52-week high and 95% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −46% fair-value upside, at −7%, V2EE34 screens cheaper than that median.
Fair Value models
Bear R$29.74Fair Value R$45.76Bull R$59.50
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (R$0.6511 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+16.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.0%
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+19.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+19.2%
Dividend (yield on the price)0.0%
Profit margin 2022 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.27% → 29%
2026 sits 70% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Veeva Systems Inc Fair Value". https://www.fairvalue-calculator.com/stock/V2EE34
Frequently asked questions
Is Veeva Systems Inc (V2EE34) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of R$45.76 versus a price of R$49.00, about −7% upside (fairly valued).
What is the fair value of V2EE34?
Our model-based fair value for Veeva Systems Inc is R$45.76 (as of Oct 3, 2026), built from audited fundamentals. The current price: R$49.00.
What is the quality score of V2EE34?
Veeva Systems Inc has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Veeva Systems Inc (V2EE34)?
Our model-based price target is the fair value of R$45.76 (as of Oct 3, 2026) from 24 valuation models. Cautious scenario R$29.74, optimistic scenario R$59.50. It is a calculation from audited fundamentals, not an analyst target.
What is the Veeva Systems Inc stock forecast for 2026?
Our models put fair value at R$45.76, about −7% upside versus a price of R$49.00 (fairly valued). Cautious scenario R$29.74, optimistic scenario R$59.50. The calculation is refreshed regularly with new filings.
What is the revenue of Veeva Systems Inc (V2EE34)?
Veeva Systems Inc reported trailing-twelve-month revenue of about $3.3B (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Veeva Systems Inc (V2EE34)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Veeva Systems Inc it is R$45.76 per share (as of Oct 3, 2026), against a price of R$49.00. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Veeva Systems Inc stock overvalued or undervalued in 2026?
As of Oct 3, 2026, V2EE34 trades above its calculated fair value: price R$49.00, fair value R$45.76, a gap of about −7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of V2EE34?
No. The price is what the market pays today (R$49.00); the fair value is what the company's own numbers justify (R$45.76). For Veeva Systems Inc the two are R$3.24 per share apart. That gap is exactly why we show both numbers side by side.
How much is Veeva Systems Inc worth?
The market values Veeva Systems Inc at about R$161B (market capitalisation, as of Oct 3, 2026). Per share that is R$49.00; our models calculate a fair value of R$45.76 per share.
What do the bullish and bearish scenarios say about V2EE34?
Our models span a range for Veeva Systems Inc: cautious scenario R$29.74, base R$45.76, optimistic R$59.50 per share (as of Oct 3, 2026, price R$49.00). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is V2EE34 from its 52-week high?
Veeva Systems Inc trades at R$49.00, about 10% below its 52-week high of R$54.25 and 95% above the low of R$25.14 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of R$45.76 is for.
Which stocks are comparable to Veeva Systems Inc?
From the same area (Healthcare) we also value Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Veeva Systems Inc stock attractive at the current price?
The data as of Oct 3, 2026: price R$49.00, calculated fair value R$45.76 (−7%), Quality Score 70/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of V2EE34 calculated?
We run Veeva Systems Inc through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of R$45.76, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Veeva Systems Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Veeva Systems Inc (V2EE34)?
The closing price on Sep 30, 2026 was R$49.00. Our model-based fair value is R$45.76, about −7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Veeva Systems Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (R$29.74 to R$59.50) leaves room in how you read the outcome.
Key figures of Veeva Systems Inc
How large is the market capitalisation of Veeva Systems Inc (V2EE34)?
The market capitalisation of Veeva Systems Inc is R$161B (≈ $30.8B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Veeva Systems Inc (V2EE34)?
The price-to-earnings ratio of Veeva Systems Inc is 50.5. Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What is the P/S ratio of Veeva Systems Inc (V2EE34)?
The price-to-sales ratio of Veeva Systems Inc is 14.4 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Veeva Systems Inc (V2EE34)?
Earnings per share at Veeva Systems Inc are R$0.9700 (price ÷ EPS = P/E 50.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Veeva Systems Inc (V2EE34)?
The net margin of Veeva Systems Inc is 28.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Veeva Systems Inc (V2EE34)?
The return on equity (ROE) of Veeva Systems Inc is 13.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Veeva Systems Inc (V2EE34)?
On an EBIT basis the return on assets of Veeva Systems Inc is 9.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Veeva Systems Inc (V2EE34)?
The operating margin of Veeva Systems Inc is 30.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Veeva Systems Inc (V2EE34)?
Revenue at Veeva Systems Inc is growing +16.3% versus a year earlier (3y avg +14.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Veeva Systems Inc (V2EE34)?
Earnings per share at Veeva Systems Inc are growing +14.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Veeva Systems Inc (V2EE34) generate?
The free cash flow of Veeva Systems Inc is $1.4B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Continue in the live analysis
Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.
